嘌呤能受体
嘌呤能信号
医学
糖尿病
受体
内科学
糖尿病神经病变
内分泌学
神经科学
神经损伤
麻醉
生物
腺苷受体
兴奋剂
标识
DOI:10.1016/j.neuropharm.2022.109406
摘要
Diabetic cardiac autonomic neuropathy is a common and serious chronic complication of diabetes, which can lead to sympathetic and parasympathetic nerve imbalance and a relative excitation of the sympathetic nerve. Purinergic receptors play a crucial role in this process. Diabetic cardiac sympathetic nerve injury affects the expression of purinergic receptors, and activated purinergic receptors affect the phosphorylation of different signaling pathways and the regulation of inflammatory processes. This paper introduces the abnormal changes of sympathetic nerve in diabetes mellitus and summarizes the recently published studies on the role of several purinergic receptor subtypes in diabetic cardiac sympathetic nerve injury. These studies suggest that purinergic receptors as novel drug targets are of great significance for the treatment of diabetic autonomic neuropathy. This article is part of the Special Issue on "Purinergic Signaling: 50 years".
科研通智能强力驱动
Strongly Powered by AbleSci AI